{
    "root": "359e91ba-a244-6357-e063-6394a90a9542",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "GABAPENTIN",
    "value": "20250521",
    "ingredients": [
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH"
        },
        {
            "name": "CROSPOVIDONE",
            "code": "2S7830E561"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "GLYCERYL DIBEHENATE",
            "code": "R8WTH25YS2"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        }
    ],
    "indications": "gabapentin tablets indicated : management postherpetic neuralgia adults adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
    "contraindications": "postherpetic neuralgia ( 2.1 ) dose titrated needed dose 1800 mg/day day 1 : single 300 mg dose day 2 : 600 mg/day ( i.e . , 300 mg two times day ) day 3 : 900 mg/day ( i.e . , 300 mg three times day ) epilepsy partial onset seizures ( 2.2 ) patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily patients 3 11 years age : starting dose range 10 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions": "gabapentin tablets , usp supplied follows : 600 mg tablets : white colored film coated , oval shaped , biconvex tablets de-bossed ‘ ’ left side bisect ‘ 1 ’ right side bisect one side bisect side ; supplied bottles 30 : ndc 76420-836-30 ( repackaged ndc 31722-166-xx ) bottles 60 : ndc 76420-836-60 ( repackaged ndc 31722-166-xx ) bottles 90 : ndc 76420-836-90 ( repackaged ndc 31722-166-xx ) bottles 100 : ndc 76420-836-01 ( relabeled ndc 31722-166-01 ) bottles 120 : ndc 76420-836-12 ( repackaged ndc 31722-166-xx ) bottles 500 : ndc 76420-836-05 ( relabeled ndc 31722-166-05 ) 800 mg tablets : white colored film coated , oval shaped , biconvex tablets de-bossed ‘ ’ left side bisect ‘ 3 ’ right side bisect one side bisect side ; supplied bottles 30 : ndc 76420-837-30 ( repackaged ndc 31722-167-xx ) bottles 60 : ndc 76420-837-60 ( repackaged ndc 31722-167-xx ) bottles 90 : ndc 76420-837-90 ( repackaged ndc 31722-167-xx ) bottles 100 : ndc 76420-837-01 ( relabeled ndc 31722-167-01 ) bottles 500 : ndc 76420-837-05 ( relabeled ndc 31722-167-05 ) store gabapentin tablets 25°c ( 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "gabapentin tablets contraindicated patients demonstrated hypersensitivity ingredients .",
    "indications_original": "Gabapentin tablets are indicated for:\n                  \n                     Management of postherpetic neuralgia in adults\n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications_original": "Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose of 1800 mg/day Day 1: Single 300 mg dose Day 2: 600 mg/day (i.e., 300 mg two times a day) Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures (2.2) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days Dose should be adjusted in patients with reduced renal function (2.3, 2.4)",
    "warningsAndPrecautions_original": "Gabapentin tablets, USP are supplied as follows:\n                  \n                  \n                  600 mg tablets:\n                  \n                  \n                  White colored film coated, Oval Shaped, biconvex tablets de-bossed with ‘T’on the left side of the bisect and ‘1’on the right side of the bisect on one side and bisect on other side; supplied in\n                  \n                  \n                  Bottles of 30: NDC 76420-836-30 (repackaged from NDC 31722-166-xx)\n                  Bottles of 60: NDC 76420-836-60 (repackaged from NDC 31722-166-xx)\n                  Bottles of 90: NDC 76420-836-90 (repackaged from NDC 31722-166-xx)\n                  Bottles of 100: NDC 76420-836-01 (relabeled from NDC 31722-166-01)\n                  Bottles of 120: NDC 76420-836-12 (repackaged from NDC 31722-166-xx)\n                  Bottles of 500: NDC 76420-836-05 (relabeled from NDC 31722-166-05)\n                  \n                  \n                  800 mg tablets:\n                  \n                  \n                  White colored film coated, Oval Shaped, biconvex tablets de-bossed with ‘T’on the left side of the bisect and ‘3’on the right side of the bisect on one side and bisect on other side; supplied in\n                  \n                  \n                  Bottles of 30: NDC 76420-837-30 (repackaged from NDC 31722-167-xx)\n                  Bottles of 60: NDC 76420-837-60 (repackaged from NDC 31722-167-xx)\n                  Bottles of 90: NDC 76420-837-90 (repackaged from NDC 31722-167-xx)\n                  Bottles of 100: NDC 76420-837-01 (relabeled from NDC 31722-167-01)\n                  Bottles of 500: NDC 76420-837-05 (relabeled from NDC 31722-167-05)\n                  \n                  \n                  Store gabapentin tablets at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Gabapentin tablets are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}